• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Biclonal follicular lymphoma: histological, clinical and molecular characteristics.

作者信息

Noriega María Fernanda, De Brasi Carlos, Narbaitz Marina, Rodríguez Andrea, Slavutsky Irma

出版信息

Pathology. 2010;42(6):598-601. doi: 10.3109/00313025.2010.508736.

DOI:10.3109/00313025.2010.508736
PMID:20854087
Abstract
摘要

相似文献

1
Biclonal follicular lymphoma: histological, clinical and molecular characteristics.双克隆滤泡性淋巴瘤：组织学、临床及分子特征
Pathology. 2010;42(6):598-601. doi: 10.3109/00313025.2010.508736.
2
Safety of fludarabine, mitoxantrone, and dexamethasone combined with rituximab in the treatment of stage IV indolent lymphoma.氟达拉滨、米托蒽醌和地塞米松联合利妥昔单抗治疗IV期惰性淋巴瘤的安全性。
Semin Oncol. 2000 Dec;27(6 Suppl 12):37-41.
3
Anthracycline-fludarabine-containing regimens with or without rituximab in the treatment of patients with advanced follicular lymphoma.含蒽环类药物和氟达拉滨的方案联合或不联合利妥昔单抗用于治疗晚期滤泡性淋巴瘤患者。
Cancer. 2009 May 1;115(9):1906-13. doi: 10.1002/cncr.24222.
4
Rituximab in combination with fludarabine and cyclophosphamide in the treatment of patients with recurrent follicular lymphoma.利妥昔单抗联合氟达拉滨和环磷酰胺治疗复发性滤泡性淋巴瘤患者
Cancer. 2007 Jul 1;110(1):121-8. doi: 10.1002/cncr.22740.
5
The UK NCRI study of chlorambucil, mitoxantrone and dexamethasone (CMD) versus fludarabine, mitoxantrone and dexamethasone (FMD) for untreated advanced stage follicular lymphoma: molecular response strongly predicts prolonged overall survival.英国 NCRI 开展的未经治疗的晚期滤泡性淋巴瘤中氯苯丁酸、米托蒽醌和地塞米松（CMD）与氟达拉滨、米托蒽醌和地塞米松（FMD）的研究：分子缓解强烈预测延长的总生存期。
Br J Haematol. 2020 Aug;190(4):545-554. doi: 10.1111/bjh.16555. Epub 2020 Mar 9.
6
[A clinical observation of fludarabine-containing regimens in the treatment of low grade non-Hodgkin's lymphoma].含氟达拉滨方案治疗低度非霍奇金淋巴瘤的临床观察
Zhonghua Zhong Liu Za Zhi. 2007 Sep;29(9):710-2.
7
A prospective randomized study to compare the molecular response rates between central lymphatic irradiation and intensive alternating triple chemotherapy in the treatment of stage I-III follicular lymphoma.一项前瞻性随机研究，比较中枢淋巴放疗与密集交替三联化疗在治疗I-III期滤泡性淋巴瘤中的分子反应率。
Int J Radiat Oncol Biol Phys. 2005 Sep 1;63(1):188-93. doi: 10.1016/j.ijrobp.2005.01.027.
8
The role of mitoxantrone in the treatment of indolent lymphomas.米托蒽醌在惰性淋巴瘤治疗中的作用。
Oncologist. 2005 Feb;10(2):150-9. doi: 10.1634/theoncologist.10-2-150.
9
A phase II study to evaluate the combination of fludarabine, mitoxantrone and dexamethasone (FMD) in patients with follicular lymphoma.一项评估氟达拉滨、米托蒽醌和地塞米松（FMD）联合用药治疗滤泡性淋巴瘤患者的II期研究。
Ann Oncol. 2000 Jul;11(7):861-5. doi: 10.1023/a:1008381105849.
10
Phase II trial of sequential therapy with fludarabine followed by cyclophosphamide, mitoxantrone, vincristine, and prednisone for low-grade follicular lymphomas.氟达拉滨序贯环磷酰胺、米托蒽醌、长春新碱及泼尼松治疗低度滤泡性淋巴瘤的II期试验
Am J Hematol. 2002 Jul;70(3):181-5. doi: 10.1002/ajh.10137.